ZOETIS INC
ZTS·98978V103·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
ZTS (ZOETIS INC) is held by 342 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($4.2B), VANGUARD CAPITAL MANAGEMENT LLC ($3.1B), VANGUARD PORTFOLIO MANAGEMENT LLC ($2.8B). Net institutional sentiment: Mixed. In Q1 2026, 3 members of Congress and 152 funds bought ZTS.
342
Holders
(51 Elite)
$42.3B
Total Value
43% (354)
Consensus
152 buying - 202 selling
13F: Insider & Congress:
Who's Trading
InsiderBPBisaro PaulBuy $152KMay 13, 2026
InsiderDADAMELIO FRANK ABuy $501KMay 13, 2026
InsiderMBMCCALLISTER MICHAEL BBuy $233KMay 11, 2026
InsiderEKEsch KevinExercise 259 shApr 30, 2026
Showing 1-20 of 360
1 / 18
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer